Diagnosis and treatment of pulmonary histoplasmosis in a horse.

This is a case study detailing the diagnosis and successful treatment of pulmonary histoplasmosis, a fungal infection, in a 2-year-old horse named Trakehner filly. The primary symptoms included weight loss, irregular fever, difficulty in breathing and depression, and the horse was treated through intravenous administration of the antifungal drug Amphotercin-B for five weeks.

Presentation of the Horse

The research article revolves around the case of a 2-year-old Trakehner filly, a specific breed of horse. The filly was suffering from:

• Weight loss
• Intermittent fever
• Dyspnea or difficulty in breathing
• Depression

Diagnosis Methodology

The researchers decided on the diagnosis of pulmonary histoplasmosis based on several medical procedures carried out on the horse.

• The diagnosis was primarily based on thoracic radiography, a specific type of X-ray technique that was used to check the filly’s chest area for abnormalities.
• A transtracheal wash cytology involved washing and sampling cells from the filly’s windpipe to detect any signs of infection.
• Lastly, a lung aspirate cytology was carried out; this consisted of drawing out fluid or cells directly from the lungs to aid in diagnosis.

Treatment Procedure

Post-diagnosis, an elaborate treatment procedure was followed.

• The filly was treated with a 5-week regimen of Amphotercin-B, a potent antifungal medication.
• This medication was administered intravenously i.e., directly into the bloodstream.
• The treatment resulted in clinical recovery and the filly’s return to normal activities.

Insights on Histoplasmosis

The study also provides a brief overview of histoplasmosis, a fungal infection that affects humans and animals.

• It typically impacts the person’s or animal’s lungs, manifesting as pulmonary histoplasmosis.
• It is generally caught by inhaling fungal spores that contaminate the environment.
• The illness can range from mild and asymptomatic to severe, depending on the individual’s immune response and level of exposure to the fungus.